| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $643K | -31.7% | -74.7% |
| Cost of Revenue | $460K | -27.7% | -42.4% |
| Gross Profit | $183K | -40.0% | -89.5% |
| R&D Expense | $591K | -12.4% | +8.8% |
| SG&A Expense | $805K | +14.5% | +1.9% |
| Operating Income | -$1.9M | -8.8% | -508.5% |
| Net Income | -$2.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.5M | +270.0% | -35.1% |
| Accounts Receivable | $624K | -33.8% | -65.9% |
| Inventory | $2.7M | +6.2% | +12.8% |
| Current Assets | $5.9M | +22.6% | -18.0% |
| Total Assets | $6.9M | +15.9% | -20.8% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$5.6M | — | — |
| Capital Expenditures | $5K | — | — |
| Investing Cash Flow | -$4K | — | — |
| Financing Cash Flow | $5.1M | — | — |
| Free Cash Flow | -$5.6M | — | — |
| -4.2% |
| -287.5% |
| EPS (Basic) | -$0.17 | +19.0% | -88.9% |
| EPS (Diluted) | -$0.17 | +19.0% | -88.9% |
| $3.5M |
| -17.9% |
| -31.4% |
| Long-term Debt | $150K | +0.0% | +0.0% |
| Total Liabilities | $4.0M | -16.1% | -30.3% |
| Stockholders' Equity | $3.0M | +189.6% | +4.7% |